Tag: China Food and Drug Administration

December 7, 2018

Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select in China

Oxford Immunotec Global (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced regulatory acceptance of the T-Cell Selectkit by the China...
May 8, 2018

Cellular Biomedicine Group Reports First Quarter 2018 Financial Results and Highlights Operational Progress

Cellular Biomedicine (NASDAQ:CBMG) a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative...
April 20, 2018

Advanced Biomedical Technologies Inc. Announces Chinese CFDA Approval of Polymer Fixation Screws

Advanced Biomedical Technologies (OTCQB:ABMT), a developer and manufacturer of orthopaedic internal fixation devices, announced today that it has received approval...
February 28, 2018

BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China

BeiGene (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of...
February 28, 2018

FibroGen Reports Fourth Quarter and Full Year 2017 Financial Results

FibroGen (NASDAQ:FGEN), a science-based biopharmaceutical company, reported financial results for the fourth quarter and full year 2017 and provided an...
July 18, 2017

Medigus and Golden Grand Expand Distribution Arrangement in China

Medigus announced the Chinese exclusive distribution agreement with Golden Grand was expanded to account for the increased interest in the...
May 24, 2017

Bionik Laboratories To Enter Chinese Market

Bionik Laboratories announced a partnership with Ginger Capital Investment Holding in order to bring its evidence-based interactive robotic systems to...